(KRT) Karat Packaging - Ratings and Ratios
Containers, Bags, Cups, Cutlery, Straws
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.88% |
| Yield on Cost 5y | 12.01% |
| Yield CAGR 5y | -3.45% |
| Payout Consistency | 97.2% |
| Payout Ratio | 117.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 42.9% |
| Value at Risk 5%th | 59.0% |
| Relative Tail Risk | -16.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.48 |
| Alpha | -33.76 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.678 |
| Beta | 0.741 |
| Beta Downside | 0.763 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.03% |
| Mean DD | 10.60% |
| Median DD | 9.33% |
Description: KRT Karat Packaging October 23, 2025
Karat Packaging Inc. (NASDAQ: KRT) manufactures and distributes a broad portfolio of single-use disposable items-including plastic, paper, biopolymer and compostable containers, cutlery, bags, and related janitorial supplies-under the Karat Earth brand. The company also offers food-service consumables (e.g., syrups, boba tea, coffee drinks) and ancillary services such as product development, design, printing, and logistics, serving national and regional distributors, restaurant chains, retailers, and direct-to-consumer channels. Founded in 2000 and headquartered in Chino, California, Karat operates primarily in the U.S. food-service packaging market.
According to its most recent Form 10-K (FY 2023), Karat reported revenue of roughly $71 million, up 12 % year-over-year, with a gross margin of ~31 %. The company’s inventory turnover improved to 5.8×, reflecting tighter supply-chain management, while cash flow from operations remained positive at $5.2 million, supporting ongoing R&D and expansion of its compostable product line.
The single-use packaging sector is being reshaped by three macro drivers: (1) escalating ESG regulations and state-level bans on single-use plastics, which boost demand for compostable alternatives; (2) sustained growth in off-premise dining (take-out, delivery), projected to expand at a 5-6 % CAGR through 2028; and (3) rising input costs for resin and pulp, which compress margins unless firms achieve scale or product-mix shifts toward higher-margin biopolymers. Karat’s focus on biopolymer-based offerings positions it to capture incremental share as retailers and chains seek compliant, low-carbon packaging.
For a deeper quantitative view of Karat’s valuation metrics and peer comparison, you might find the ValueRay platform’s analyst toolkit useful for next-step research.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (30.3m TTM) > 0 and > 6% of Revenue (6% = 27.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -8.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 20.07% (prev 27.75%; Δ -7.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 26.7m <= Net Income 30.3m (YES >=105%, WARN >=100%) |
| Net Debt (68.0m) to EBITDA (63.7m) ratio: 1.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (20.2m) change vs 12m ago 0.31% (target <= -2.0% for YES) |
| Gross Margin 38.04% (prev 38.07%; Δ -0.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 148.9% (prev 135.8%; Δ 13.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.05 (EBITDA TTM 63.7m / Interest Expense TTM 4.14m) >= 6 (WARN >= 3) |
Altman Z'' 4.15
| (A) 0.30 = (Total Current Assets 170.7m - Total Current Liabilities 79.6m) / Total Assets 302.8m |
| (B) 0.21 = Retained Earnings (Balance) 63.9m / Total Assets 302.8m |
| (C) 0.15 = EBIT TTM 45.8m / Avg Total Assets 304.8m |
| (D) 0.45 = Book Value of Equity 63.9m / Total Liabilities 141.3m |
| Total Rating: 4.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.03
| 1. Piotroski 5.50pt |
| 2. FCF Yield 4.25% |
| 3. FCF Margin 4.89% |
| 4. Debt/Equity 0.60 |
| 5. Debt/Ebitda 1.07 |
| 6. ROIC - WACC (= 9.63)% |
| 7. RoE 19.56% |
| 8. Rev. Trend 47.74% |
| 9. EPS Trend 18.67% |
What is the price of KRT shares?
Over the past week, the price has changed by -0.39%, over one month by +8.14%, over three months by -3.80% and over the past year by -18.95%.
Is KRT a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the KRT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.5 | 24.8% |
| Analysts Target Price | 28.5 | 24.8% |
| ValueRay Target Price | 26.3 | 15.3% |
KRT Fundamental Data Overview December 19, 2025
P/E Trailing = 15.6026
P/S = 1.0436
P/B = 3.0599
Beta = 1.06
Revenue TTM = 453.8m USD
EBIT TTM = 45.8m USD
EBITDA TTM = 63.7m USD
Long Term Debt = 47.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 33.7m USD (from shortTermDebt, last quarter)
Debt = 92.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 68.0m USD (from netDebt column, last quarter)
Enterprise Value = 521.6m USD (473.5m + Debt 92.0m - CCE 44.0m)
Interest Coverage Ratio = 11.05 (Ebit TTM 45.8m / Interest Expense TTM 4.14m)
FCF Yield = 4.25% (FCF TTM 22.2m / Enterprise Value 521.6m)
FCF Margin = 4.89% (FCF TTM 22.2m / Revenue TTM 453.8m)
Net Margin = 6.67% (Net Income TTM 30.3m / Revenue TTM 453.8m)
Gross Margin = 38.04% ((Revenue TTM 453.8m - Cost of Revenue TTM 281.2m) / Revenue TTM)
Gross Margin QoQ = 34.47% (prev 39.61%)
Tobins Q-Ratio = 1.72 (Enterprise Value 521.6m / Total Assets 302.8m)
Interest Expense / Debt = 2.82% (Interest Expense 2.60m / Debt 92.0m)
Taxrate = 23.26% (2.30m / 9.91m)
NOPAT = 35.2m (EBIT 45.8m * (1 - 23.26%))
Current Ratio = 2.14 (Total Current Assets 170.7m / Total Current Liabilities 79.6m)
Debt / Equity = 0.60 (Debt 92.0m / totalStockholderEquity, last quarter 154.5m)
Debt / EBITDA = 1.07 (Net Debt 68.0m / EBITDA 63.7m)
Debt / FCF = 3.07 (Net Debt 68.0m / FCF TTM 22.2m)
Total Stockholder Equity = 154.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.00% (Net Income 30.3m / Total Assets 302.8m)
RoE = 19.56% (Net Income TTM 30.3m / Total Stockholder Equity 154.8m)
RoCE = 22.67% (EBIT 45.8m / Capital Employed (Equity 154.8m + L.T.Debt 47.3m))
RoIC = 17.31% (NOPAT 35.2m / Invested Capital 203.1m)
WACC = 7.68% (E(473.5m)/V(565.6m) * Re(8.75%) + D(92.0m)/V(565.6m) * Rd(2.82%) * (1-Tc(0.23)))
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.44%
[DCF Debug] Terminal Value 74.98% ; FCFE base≈33.0m ; Y1≈31.5m ; Y5≈30.4m
Fair Price DCF = 23.73 (DCF Value 477.0m / Shares Outstanding 20.1m; 5y FCF grow -6.05% → 3.0% )
EPS Correlation: 18.67 | EPS CAGR: 3.95% | SUE: 0.17 | # QB: 0
Revenue Correlation: 47.74 | Revenue CAGR: 8.62% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.67 | Chg30d=-0.120 | Revisions Net=-1 | Growth EPS=+7.7% | Growth Revenue=+11.1%
Additional Sources for KRT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle